194 related articles for article (PubMed ID: 12189003)
1. Buprenorphine dosing regime in the management of out-patient heroin withdrawal.
Lintzeris N
Drug Alcohol Rev; 2002 Mar; 21(1):39-45. PubMed ID: 12189003
[TBL] [Abstract][Full Text] [Related]
2. Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients.
Ang-Lee K; Oreskovich MR; Saxon AJ; Jaffe C; Meredith C; Ellis ML; Malte CA; Knox PC
J Psychoactive Drugs; 2006 Dec; 38(4):505-12. PubMed ID: 17373566
[TBL] [Abstract][Full Text] [Related]
3. Rapid heroin detoxification using a single high dose of buprenorphine.
Kutz I; Reznik V
J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
[TBL] [Abstract][Full Text] [Related]
4. Treatment of heroin addicts using buprenorphine.
Kosten TR; Morgan C; Kleber HD
Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
[TBL] [Abstract][Full Text] [Related]
5. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
6. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
[TBL] [Abstract][Full Text] [Related]
7. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.
Clark NC; Lintzeris N; Muhleisen PJ
Med J Aust; 2002 Feb; 176(4):166-7. PubMed ID: 11913917
[TBL] [Abstract][Full Text] [Related]
8. Development of buprenorphine for the treatment of opioid dependence.
Johnson RE; Fudala PJ
NIDA Res Monogr; 1992; 121():120-41. PubMed ID: 1383825
[TBL] [Abstract][Full Text] [Related]
9. Heroin detoxification with a single high dose of buprenorphine.
Kutz I; Reznik V
Isr J Psychiatry Relat Sci; 2002; 39(2):113-9. PubMed ID: 12227226
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal.
Doran CM; Shanahan M; Bell J; Gibson A
Drug Alcohol Rev; 2004 Jun; 23(2):171-5. PubMed ID: 15370023
[TBL] [Abstract][Full Text] [Related]
11. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
12. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
De S; Jain R; Ray R; Dhawan A; Varghese ST
Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
[TBL] [Abstract][Full Text] [Related]
13. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study.
Lintzeris N; Bammer G; Rushworth L; Jolley DJ; Whelan G
Drug Alcohol Depend; 2003 Jun; 70(3):287-94. PubMed ID: 12757966
[TBL] [Abstract][Full Text] [Related]
15. Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study.
Daulouède JP; Caer Y; Galland P; Villeger P; Brunelle E; Bachellier J; Piquet JM; Harbonnier J; Leglise Y; Courty P
J Subst Abuse Treat; 2010 Jan; 38(1):83-9. PubMed ID: 19800758
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
Addiction; 2007 Oct; 102(10):1648-56. PubMed ID: 17854341
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine: an alternative to methadone for heroin dependence treatment.
Resnick RB; Galanter M; Pycha C; Cohen A; Grandison P; Flood N
Psychopharmacol Bull; 1992; 28(1):109-13. PubMed ID: 1609035
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
Hakansson A; Medvedeo A; Andersson M; Berglund M
Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
[TBL] [Abstract][Full Text] [Related]
19. [Experience of using injectable formulation of buprenorphine for the detoxification treatment of heroin dependence patients].
Aso K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Jun; 44(3):156-66. PubMed ID: 19618840
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]